CAPITAL STOCK AND SHARE-BASED COMPENSATION (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 Months Ended |
2 Months Ended |
3 Months Ended |
6 Months Ended |
9 Months Ended |
|
|
|
|
|
Sep. 29, 2026 |
Sep. 17, 2026 |
Jul. 28, 2026 |
Jul. 24, 2026 |
Jul. 23, 2026 |
Jul. 13, 2026 |
Jun. 19, 2026 |
Jun. 04, 2026 |
May 29, 2026 |
Apr. 28, 2026 |
Apr. 27, 2026 |
Mar. 30, 2026 |
Mar. 13, 2026 |
Feb. 06, 2026 |
Feb. 03, 2026 |
Oct. 31, 2025 |
Mar. 06, 2025 |
Jun. 30, 2026 |
May 31, 2026 |
Apr. 30, 2026 |
Feb. 28, 2026 |
Sep. 30, 2026 |
Sep. 30, 2026 |
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2026 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Aug. 31, 2026 |
Jul. 31, 2026 |
Dec. 31, 2025 |
Jul. 03, 2024 |
Feb. 15, 2022 |
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
$ 0.001
|
|
|
|
$ 0.001
|
|
|
|
$ 0.001
|
|
|
| Preferred stock,shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000,000
|
5,000,000
|
|
|
|
5,000,000
|
|
|
|
5,000,000
|
|
|
| Preferred stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
| Preferred stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0
|
0
|
|
|
|
0
|
|
|
|
0
|
|
|
| Common stock, par value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
$ 0.001
|
|
|
|
$ 0.001
|
|
|
|
$ 0.001
|
|
$ 0.001
|
| Common stock, shares authorized |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000,000
|
500,000,000
|
|
|
|
500,000,000
|
|
|
|
500,000,000
|
|
500,000,000
|
| Warrants to purchase, share exercise |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,748,971
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
657,876
|
|
100,000
|
|
50,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,577,376
|
|
|
|
|
|
|
| Warrants forefeiture |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
226,029
|
|
|
|
|
|
226,029
|
|
|
|
|
|
|
| Conversion of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
19,223
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Conversion of value |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 8,579
|
|
|
|
|
|
|
|
|
|
|
$ 8,579
|
|
|
|
|
|
|
|
|
| Restricted stock units vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,574
|
|
|
|
|
|
|
| Restricted common stock shares issued |
|
|
20,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
249,000
|
|
|
|
|
|
|
|
|
|
| Share issued price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.00
|
|
|
|
|
|
$ 5.00
|
|
$ 5.00
|
|
|
|
|
|
|
|
| Restricted common stock shares issued value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,245,000
|
|
|
|
|
|
|
|
|
|
| Share issued value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 450,000
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
$ 5.00
|
|
$ 5.00
|
$ 5.00
|
|
$ 5.00
|
$ 5.00
|
$ 5.00
|
|
$ 5.00
|
|
|
|
|
$ 5.50
|
$ 1.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.397
|
|
| Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,146,824
|
13,146,824
|
|
|
|
13,146,824
|
|
|
|
9,785,056
|
|
|
| Common stock, shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13,146,824
|
13,146,824
|
|
|
|
13,146,824
|
|
|
|
9,785,056
|
|
|
| Common stock, shares issuable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15,000
|
15,000
|
|
|
|
15,000
|
|
|
|
0
|
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,256,803
|
|
|
|
|
|
|
| Stock issued during period value new issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 450,000
|
$ 1,495,000
|
$ 650,000
|
|
|
|
|
|
|
|
|
| Weighted-average remaining term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years 4 months 9 days
|
|
|
|
|
|
|
| Number of shares granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,548,508
|
|
|
|
|
|
|
| Aggregate number of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,500,000
|
1,500,000
|
|
|
|
1,500,000
|
|
|
|
|
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,792,757
|
$ 1,750,670
|
|
|
|
|
|
| Warrants to purchase shares |
|
50,000
|
|
4,500
|
200,000
|
|
|
|
|
|
|
|
|
|
|
1,000,000
|
100,000
|
|
|
|
|
65,000
|
65,000
|
|
|
|
65,000
|
|
65,000
|
4,500
|
|
2,975,000
|
|
| Fair value of the warrants |
|
$ 302,541
|
|
$ 29,132
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 8,653,480
|
$ 2,033,957
|
|
|
|
|
|
| Warrants expire |
|
|
|
|
|
|
Jun. 19, 2028
|
|
|
|
Apr. 26, 2031
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable description |
|
|
|
|
|
|
The warrants may be exercised only on
a cash basis and include a 4.999% beneficial ownership limitation, which may be increased to 9.999% by a holder upon at least 61 days’
prior written notice to the Company.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants issued in acquisition of intangibles |
|
|
|
|
|
|
|
$ 1,743,829
|
|
|
|
|
|
|
|
|
|
$ 1,743,829
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Darren Cahill [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants expire |
|
|
|
|
|
|
|
Jun. 04, 2031
|
|
|
|
|
|
|
|
|
Mar. 05, 2030
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable description |
|
|
|
|
|
|
|
The warrants are exercisable as
to one half of the shares of common stock immediately, and exercisable as to the remaining half of the shares of common stock one year
following the grant date of the warrants.
|
|
|
|
|
|
|
|
|
The warrants are exercisable as to one half of the shares of common stock immediately, and exercisable as to the remaining half
of the shares of common stock one year following the grant date of the warrants.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| George Mackin [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants expire |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Feb. 02, 2029
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The warrants are exercisable as to one half of the shares of common stock immediately, and exercisable as to the remaining half
of the shares of common stock one year following the grant date of the warrants.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Justin Gimblestob [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants expire |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mar. 05, 2030
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The warrants are exercisable as to one half of the shares of common stock immediately, and exercisable as to the remaining half of the
shares of common stock one year following the grant date of the warrants.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trademark Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.75
|
$ 5.75
|
|
|
|
$ 5.75
|
|
|
|
|
|
|
| Warrants exercisable description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The warrants include a 4.999% beneficial ownership limitation, which can be
increased to 9.999% by either holder, with at least 61 days prior written notice to the Company.
|
|
|
|
|
|
|
| Stefanie Graf [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants expire |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oct. 31, 2030
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted Stock Units (RSUs) [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted stock units vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares unvested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
500,000
|
500,000
|
|
|
|
500,000
|
|
|
|
|
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 135,155
|
|
|
|
$ 215,954
|
|
|
|
|
|
|
| Employee service share based compensation nonvested awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,309,046
|
$ 2,309,046
|
|
|
|
$ 2,309,046
|
|
|
|
|
|
|
| Number of shares granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
319,500
|
|
|
|
500,000
|
|
|
|
|
|
|
| Grant-date fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.05
|
|
|
|
|
|
|
| Nonvested award, cost not yet recognized, period for recognition |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2 years 6 months 21 days
|
|
|
|
|
|
|
| Restricted Stock Awards [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
60,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 330,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
50,000
|
|
|
|
50,000
|
|
|
|
|
|
|
| Shares unvested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
10,000
|
|
|
|
10,000
|
|
|
|
|
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 165,000
|
|
|
|
$ 275,000
|
|
|
|
|
|
|
| Restricted Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9,574
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share vested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
69,574
|
69,574
|
|
|
|
69,574
|
|
|
|
|
|
|
| Shares unvested |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10,000
|
10,000
|
|
|
|
10,000
|
|
|
|
|
|
|
| Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
$ 45,000
|
|
|
|
|
|
|
| Stock issued during period value new issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 45,000
|
|
|
|
|
|
|
|
| Allocated share based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
165,000
|
|
|
|
320,000
|
|
|
|
|
|
|
| Employee service share based compensation nonvested awards |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 55,000
|
$ 55,000
|
|
|
|
$ 55,000
|
|
|
|
|
|
|
| Subscription Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5.00
|
$ 5.00
|
|
|
|
$ 5.00
|
|
|
|
|
|
|
| Number of shares sold |
|
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65,000
|
|
|
|
|
|
|
|
|
|
|
|
| Capital units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
65,000
|
65,000
|
|
|
|
65,000
|
|
|
|
|
|
|
| Warrant term |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 years
|
3 years
|
|
|
|
3 years
|
|
|
|
|
|
|
| Gross proceeds from issuance of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 450,000
|
|
|
|
|
|
|
|
|
|
|
| Investments AKA, LLC [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued |
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
299,000
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase, share exercise |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
705,417
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
651,231
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued price per share |
|
|
|
|
|
|
|
|
|
$ 5.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued value |
|
|
$ 3,000,000
|
|
|
|
|
|
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceed of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,495,000
|
|
|
|
|
|
|
|
|
|
| Stock issued during period value new issues |
|
|
|
|
|
|
|
|
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
705,417
|
|
| Investor [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted common stock shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
80,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued price per share |
|
|
|
|
|
|
|
|
|
|
|
$ 5.00
|
$ 5.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted common stock shares issued value |
|
|
|
|
|
|
|
|
|
|
|
$ 250,000
|
$ 400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Investor [Member] | Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted common stock shares issued |
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Boreta Lifetime Trust [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued |
|
|
|
|
|
|
|
|
|
|
|
|
50,000
|
|
|
|
|
|
50,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued value |
|
|
|
|
|
|
|
|
|
|
|
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issued during period value new issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| James Askew [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase, share exercise |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,269,583
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,097,740
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chief Financial Officer [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants expire |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mar. 05, 2030
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants exercisable description |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The warrants are exercisable as to one half of the shares of common stock immediately, and exercisable
as to the remaining half of the shares of common stock one year following the grant date of the warrants.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member] | 2026 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consultant [Member] | Restricted Stock Units (RSUs) [Member] | 2026 Plan [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares granted |
200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Grant-date fair value |
$ 5.05
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,748,971
|
|
90,000
|
299,000
|
130,000
|
|
|
|
|
|
|
|
|
| Conversion of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19,223
|
|
|
|
|
|
|
|
|
| Conversion of value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 19
|
|
|
|
|
|
|
|
|
| Gross proceed of shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,000
|
|
|
|
|
|
|
|
|
|
|
| Number of shares sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
90,000
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7.00
|
$ 7.00
|
|
|
|
$ 7.00
|
|
$ 7.00
|
|
|
|
|
| Stock issued during period value new issues |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 90
|
$ 299
|
$ 130
|
|
|
|
|
|
|
|
|
| Common Stock [Member] | Subscription Agreements [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.00
|
$ 5.00
|
|
|
|
5.00
|
|
|
|
|
|
|
| Number of shares sold |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
25,000
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7.00
|
$ 7.00
|
|
|
|
$ 7.00
|
|
|
|
|
|
|
| Restricted Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted common stock shares issued |
|
|
20,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Restricted common stock shares issued,value |
|
|
$ 130,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
$ 6.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share issued |
|
|
|
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock issued during period value new issues |
|
|
|
|
|
|
|
$ 1,743,829
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1,104,339
|
|
|
|
|
|
|
| Aggregate number of shares |
|
|
|
|
200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price |
|
|
|
|
$ 5.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock-based compensation expense |
|
|
|
|
$ 1,275,348
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|